Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
01/08/2008 | CA2439291C Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists |
01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
01/08/2008 | CA2410237C Adenosine a2a receptor antagonists |
01/08/2008 | CA2402668C Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
01/08/2008 | CA2394027C New derivatives of octahydro-2h-pyrido[1,2-a] pyrazine, their preparation process and pharmaceutical compositions that contain them |
01/08/2008 | CA2389170C A process for the production of epinastine hydrochloride in the high-melting crystal modification |
01/08/2008 | CA2388716C Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
01/08/2008 | CA2335079C Composition for the treatement of immune deficiencies and methods for its preparation and use |
01/08/2008 | CA2296031C Novel spiroazabicyclic heterocyclic compounds |
01/08/2008 | CA2272720C New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them |
01/08/2008 | CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
01/08/2008 | CA2203901C Polymeric wound healing accelerators |
01/08/2008 | CA2121716C Method and medical agent for diagnosis of arthritis |
01/03/2008 | WO2008002674A2 Bicyclic compositions and methods for modulating a kinase cascade |
01/03/2008 | WO2008002514A2 Combination cough treatment compounds and method of treating common coughs |
01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
01/03/2008 | WO2008001956A1 Therapeutic agent for liver fibrosis |
01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |
01/03/2008 | WO2008001929A1 Treatment agent for inflammatory bowel disease |
01/03/2008 | WO2008001912A1 Substituted benzyl ester derivative and use thereof |
01/03/2008 | WO2008001886A1 Aurora inhibitor |
01/03/2008 | WO2008001885A1 Abl KINASE INHIBITOR |
01/03/2008 | WO2008001883A1 α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
01/03/2008 | WO2008001864A1 C-phenyl 1-thioglucitol compound |
01/03/2008 | WO2008001778A1 Genetically modified animal and use thereof |
01/03/2008 | WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin |
01/03/2008 | WO2008001734A1 Compressed preparation |
01/03/2008 | WO2008001502A1 Potentiator of radiation therapy |
01/03/2008 | WO2008001491A1 Antiallergic agent |
01/03/2008 | WO2008001101A2 Pharmaceutical combinations |
01/03/2008 | US20080004613 Methods and devices for treatment of migraines |
01/03/2008 | US20080004561 Method for Treating Oncological, Virulent and Somatic Diseases, Method for Controlling Treatment Efficiency, Pharmaceutical Agents and Composition for Carrying Out Said Treatment |
01/03/2008 | US20080004435 Corticotropin releasing factor 2 receptor agonists |
01/03/2008 | US20080004346 Methods and Compositions for Treatment of Intraepithelial Neoplasia |
01/03/2008 | US20080004329 Pharmaceutical compositions of ropinirole and methods of use thereof |
01/03/2008 | US20080004321 Potentiators of Glutamate Receptors |
01/03/2008 | US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
01/03/2008 | US20080004300 protein kinase inhibitors such as N-[5-(4,4-Dimethyl-2,5-dioxo-3-pyridin-4-ylmethyl-imidazolidin-1-yl)-2-trifluoromethoxy-phenyl]-2-morpholin-4-yl-acetamide, used for treating tumors; antitumor and anticarcinogenic agents |
01/03/2008 | US20080004294 Heterocyclic compounds |
01/03/2008 | US20080004293 Adenosine receptor antagonists and methods of making and using the same |
01/03/2008 | US20080004287 Human Double Minute 2 (HDM2) protein inhibitors; anticancer agents |
01/03/2008 | US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors |
01/03/2008 | US20080004247 Combinations of Statins with Bronchodilators |
01/03/2008 | US20080004236 High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections |
01/03/2008 | US20080004230 SAM Riboswitch and Uses Thereof |
01/03/2008 | US20080004228 New Expression Tools for Multiprotein Applications |
01/03/2008 | US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level |
01/03/2008 | US20080004208 Methods for Diagnosis and Prognosis of Malignant Lymphoma |
01/03/2008 | US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
01/03/2008 | US20080003311 Rosmarinus extracts for inhibiting/treating skin aging |
01/03/2008 | US20080003304 Combination chemotherapy |
01/03/2008 | US20080003303 Nutraceutical treatments for diabetic and non-diabetic wound healing |
01/03/2008 | US20080003302 Method And Nutraceutical Composition For Mammals |
01/03/2008 | US20080003297 Taste-masking oral dosage form and method of preparing the same |
01/03/2008 | US20080003294 Methods for pulmonary delivery of interleukin-2 |
01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
01/03/2008 | US20080003280 Combination cough treatment compounds and method of treating common coughs |
01/03/2008 | US20080003258 Composition and Method for Treating Rheumatoid Arthritis |
01/03/2008 | US20080003257 Composition and Method for Treating Connective Tissue Damage |
01/03/2008 | US20080003243 Oral Anti-Protozoiasis Vaccines Based on Transgenic Plants |
01/03/2008 | US20080003239 Yeast-based Vaccine for Inducing an Immune Response |
01/03/2008 | US20080003237 Gram Positive Bacterial Cells Comprising a Disrupted Flagellin Gene, Flagellin-Based Fusion Proteins and Use in Removal of Metal Ions from a Liquid |
01/03/2008 | US20080003236 Adenovirus fiber shaft composition and methods of use |
01/03/2008 | US20080003226 Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents |
01/03/2008 | US20080003206 ABCB5 positive mesenchymal stem cells as immunomodulators |
01/03/2008 | US20080003204 Compositions and methods for treating cystic fibrosis |
01/03/2008 | US20080003201 Interleukin-12 as a veterinary vaccine adjuvant |
01/03/2008 | US20080003198 Hernia treatment agents |
01/03/2008 | US20080003186 Material for inhibiting enamel demineralization |
01/03/2008 | CA2656165A1 Bicyclic compositions and methods for modulating a kinase cascade |
01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
01/03/2008 | CA2655999A1 Treating agent of inflammatory bowel disease |
01/03/2008 | CA2655937A1 C-phenyl 1-thioglucitol compound |
01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
01/03/2008 | CA2652811A1 Potentiator of radiation therapy |
01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
01/02/2008 | EP1873148A1 pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid |
01/02/2008 | EP1873144A1 Fused heterocyclic compound |
01/02/2008 | EP1872797A2 Treatment of cardiovascular and related pathologies |
01/02/2008 | EP1872785A1 pharmaceutical composition comprising condensed indole compound |
01/02/2008 | EP1872780A2 Omega-Phenyloctanamides as therapeutic compounds |
01/02/2008 | EP1651201B1 Necrosis avid tracer agent |
01/02/2008 | EP1465614B1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
01/02/2008 | EP1448223B1 Thymosin augmentation of genetic immunization |
01/02/2008 | EP1443942B1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonate, a cox-2 inhibitor and a taxol |
01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
01/02/2008 | EP1391198B1 Novel sphingolipid synthesis inhibitor |
01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
01/02/2008 | EP1263739B1 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
01/02/2008 | EP0988044B1 Water/ethanol centipeda cunninghamii plant extract |
01/02/2008 | CN101098894A High-molecular fucoidan, method of producing the same and cosmetic composition |